- Home
- JNJ vs GOOGM Comparison
JNJ vs GOOGM Comparison
Compare JNJ & GOOGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$271.11
GOOGM
Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series A Mandatory Convertible Preferred Stock
Current Price
$48.85
Company Overview
Basic Information| Metric | JNJ | GOOGM |
|---|---|---|
| Founded | 1886 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 624.3B |
| IPO Year | 2003 | 2015 |
Fundamental Metrics
Financial Performance| Metric | JNJ | GOOGM |
|---|---|---|
| Price | $271.11 | $48.85 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $238.20 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 1.0M |
| Earning Date | 04-14-2026 | N/A |
| Dividend Yield | ★ 2.36% | N/A |
| EPS Growth | ★ 90.50 | 34.45 |
| EPS | 4.41 | ★ 14.24 |
| Revenue | N/A | ★ $402,836,000,000.00 |
| Revenue This Year | $6.63 | N/A |
| Revenue Next Year | $7.43 | N/A |
| P/E Ratio | $59.49 | ★ $3.44 |
| Revenue Growth | N/A | ★ 15.09 |
| 52 Week Low | $173.33 | $46.24 |
| 52 Week High | $274.90 | $53.13 |
Technical Indicators
Market Signals| Indicator | JNJ | GOOGM |
|---|---|---|
| Relative Strength Index (RSI) | 66.32 | 45.49 |
| Support Level | $247.97 | $48.45 |
| Resistance Level | $272.16 | $52.44 |
| Average True Range (ATR) | 5.16 | 1.01 |
| MACD | 0.35 | -0.14 |
| Stochastic Oscillator | 93.85 | 16.28 |
Price Performance
Historical Comparison JNJ
GOOGM
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.